Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension of its cooperative research and development agreement with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). This partnership supports the continued development of NES100, an intranasal peptide product designed […]